Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Shanghai Fosun Pharmaceutical (Group) Co ( (HK:2196) ) has issued an update.
Shanghai Fosun Pharmaceutical has announced the election of Ms. Yan Jia as the employee director for the tenth session of its board. This decision follows a resolution to amend the Articles of Association, allowing employee directors to be elected without shareholder approval, which could enhance employee representation and influence in the company’s governance.
More about Shanghai Fosun Pharmaceutical (Group) Co
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a joint stock limited company based in China, primarily engaged in the pharmaceutical industry. The company focuses on the development, manufacture, and sale of pharmaceutical products and medical devices, with a significant emphasis on innovative drugs.
Average Trading Volume: 5,768,336
Technical Sentiment Signal: Buy
Current Market Cap: HK$67.95B
See more insights into 2196 stock on TipRanks’ Stock Analysis page.